Feedback / Questions
AD182 - Apnimed
AD504 - Apnimed
https://www.businesswire.com/news/home/20211116005238/en/Apnimed-Achieves-Meaningful-Results-in-Proof-of-Concept-Crossover-Study-With-Oral-Therapeutic-Candidates-AD504-and-AD182-for-the-Treatment-of-Obstructive-Sleep-Apnea
Nov 16, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next